U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H15NO4
Molecular Weight 309.316
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AMINAPHTHONE

SMILES

CC1=C(OC(=O)C2=CC=C(N)C=C2)C(O)=C3C=CC=CC3=C1O

InChI

InChIKey=YLMPBJUYFTWHKJ-UHFFFAOYSA-N
InChI=1S/C18H15NO4/c1-10-15(20)13-4-2-3-5-14(13)16(21)17(10)23-18(22)11-6-8-12(19)9-7-11/h2-9,20-21H,19H2,1H3

HIDE SMILES / InChI
Aminaphtone, a synthetic molecule derived from 4-aminobenzoic acid, is a drug affecting vessel functioning. Aminaphtone significantly protects endothelium permeability and stabilises endothelial cells organised in capillary-like structures, modulating VE-cadherin expression. In addition aminaphtone modulate expression of several inflammatory and vasoactive factors. Aminaphtone (Capilarema) is used in the treatment of vascular disorders, especially chronic venous disease.

Approval Year

Sample Use Guides

2 tablets (75 mg) 2 times daily for 5 days
Route of Administration: Oral
ECV-304 endothelial cells were stimulated with IL-1β 100U/ml in the presence or absence of Aminaphtone 6 μg/ml
Name Type Language
AMINAPHTONE
WHO-DD  
Preferred Name English
AMINAPHTHONE
MART.  
Common Name English
1,2,4-NAPHTHALENETRIOL, 3-METHYL-, 2-(P-AMINOBENZOATE)
Common Name English
1,2,4-NAPHTHALENETRIOL, 3-METHYL-, 2-(4-AMINOBENZOATE)
Common Name English
CAPILLAREMA
Brand Name English
Aminaphtone [WHO-DD]
Common Name English
AMINAFTONE
Common Name English
AMINAPHTHONE [MART.]
Common Name English
(1,4-DIHYDROXY-3-METHYLNAPHTHALEN-2-YL) 4-AMINOBENZOATE
Systematic Name English
AMINONAPHTHONE
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID00163725
Created by admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
PRIMARY
EVMPD
SUB12847MIG
Created by admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
PRIMARY
ECHA (EC/EINECS)
238-809-8
Created by admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
PRIMARY
CAS
14748-94-8
Created by admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
PRIMARY
RXCUI
46276
Created by admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
PRIMARY RxNorm
SMS_ID
100000077685
Created by admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
PRIMARY
FDA UNII
03JLX11PE9
Created by admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
PRIMARY
DRUG BANK
DB13039
Created by admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
PRIMARY
DRUG CENTRAL
159
Created by admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
PRIMARY
PUBCHEM
84621
Created by admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
PRIMARY